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PURPOSE. We estimate and compare change in iris cross-sectional area (IA) after physiologic
and pharmacologic mydriasis in subjects with different dominant mechanisms for primary
angle closure.
METHODS. Anterior segment optical coherence tomography (AS-OCT) measurements in light,
dark, and following pharmacologic dilation were obtained on primary angle closure suspects
(PACS), primary angle closure (PAC), and primary angle closure glaucoma (PACG) examined
during the 5-year follow-up of the Handan Eye Study. Subjects were categorized into three
subgroups according to their dominant angle closure (AC) mechanisms as determined by AS-
OCT: pupillary block (PB), plateau iris configuration (PIC), and thick peripheral iris roll
(TPIR). The IA and other biometric parameters measured using the Zhongshan Angle
Assessment Program in the right eyes of all subjects were analyzed.
RESULTS. A total of 364 right eyes of subjects with PACS (333), and PAC/PACG (31) was
included in the analysis. Significant differences in the change of IAs (P ¼ 0.030), IA loss per
mm pupil diameter (PD) increase (P ¼ 0.001) in light versus pharmacologic dilation, and IA
loss per mm PD increase (P ¼ 0.011) from dark versus pharmacologic dilation were observed
among the three groups. The smallest decrease occurred in the PB group.
CONCLUSIONS. There are significant differences in IA and IA loss per mm of pupil change
following physiologic or pharmacologic mydriasis in Chinese subjects with dissimilar
dominant mechanisms for AC. Dynamic iris change may have a more important role in angle
closure where PB is the dominant mechanism.
Keywords: primary angle closure disease, iris cross-sectional area, anterior segment optical
coherence tomography, angle closure mechanism
The International Society of Geographical and Epidemiolog-ical Ophthalmology (ISGEO) classification for primary angle
closure (PAC) includes primary angle closure suspect (PACS),
PAC, and primary angle closure glaucoma (PACG).1,2 The PACS
essentially is a risk factor for disease and is defined as eyes
where the posterior trabecular meshwork is not visible for at
least 1808, IOP  21 mm, no peripheral anterior synechiae
(PAS) with healthy optic nerves.3 The presence of raised IOP
(>21 mmHg) and/or PAS in a PACS is termed PAC, while the
term PACG is used only in the presence of glaucomatous optic
neuropathy (GON)/visual field loss with PAC.1,2 In this report,
we refer to PAC and PACG as primary angle closure disease
(PACD).
Recent reports support the concept that PAC is a multifactorial
disease caused by a combination of anatomical and dynamic (iris
and choroid) components.4–7 While anatomical factors have been
extensively investigated, the role of dynamic elements is less
clear.8–12 Analysis of such dynamic iris behavior may provide clues
to understanding which eyes might develop angle closure (AC)
and perhaps explain the higher prevalence of PACD among
Asians, as compared to Europeans and Africans.8,13–16
Using anterior segment optical coherence tomography (AS-
OCT), Quigley et al.8 reported that a smaller change in iris cross-
sectional area (IA) with pupil dilation could be a potential risk
factor for AC in those with European ancestry. They hypothesized
that a smaller decrease in iris volume (IV) on dilation may present
a higher risk of AC.8 In South Indians, IA and IV decreased with
pupillary dilatation in normal and AC eyes; the loss of IV was lower
with AC.10 It is hypothesized that high fluid content of the iris
stroma combined with a reduction in the transfer of extracellular
fluid to the anterior chamber due to compact or water-retentive
stroma could affect change in IA and IV as the pupil dilates, a
dynamic factor that could predispose some anatomically suscep-
tible eyes to PAC.8–10,17–20 Our previous research in a rural
Chinese population showed that PACS and normal eyes respond
differently to physiologic and pharmacologic pupillary dilation,
with the former showing a smaller reduction in IA and IV.21 Such
differences in iris behavior may partly explain why only a small
proportion of PACS eyes develop PACD.
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Aptel and Denis9 reported that IV estimated with the AS-OCT,
increased after pupil dilation in narrow-angle eyes predisposed to
acute angle closure (AAC). They also found that this biometric
change was associated with angle narrowing, despite a patent
laser peripheral iridotomy (LPI).9 However, the increase in iris
volume in some eyes is likely to be due to a fallacy in the formula
used for its calculation.22 Narayanaswamy et al.20 reported that
the IV decreased in eyes with chronic AC following physiologic
mydriasis, but remained unchanged in fellow eyes of AAC. These
findings suggested that variations in iris responses may influence
the subtype of AC that develops and perhaps have more of a role
in AAC. A recent study reports that eyes with loss in IA, but a
paradoxical increase in IV had larger increase in centroid-to-
centroid distance (the distance between the centers of right and
left iris masses, CCD) relative to the increase in pupil size, than did
the eyes with IA and IV loss.22 Hence, IA may be a better
parameter that represents iris dynamic change, compared to IV
change.
Chinese eyes too seem to have multiple mechanisms for
AC.23–25 Using ultrasound biomicroscopy (UBM) Wang et al.23
reported the following mechanisms for AC in Chinese eyes:
pure pupillary block (38.1%), pure nonpupillary block (7.1%),
and multiple mechanisms (54.8%); multiple mechanisms were
the commonest. The AC mechanism involved in most AAC is
predominantly pupillary block (PB), while nonpupillary block
or multiple mechanism have a greater role in nonacute
presentations.26,27 In complex disorders like PAC, all individ-
uals with disease do not share the same set of risk factors and
the framework of a sufficient component causal model is useful
in identifying individual mechanisms of causation.6 While
pupillary block is a possible universal necessary component of
all sufficient component cause models of PAC, identification of
other component mechanisms that can be addressed is likely to
be clinically useful.6 We hypothesized that the contribution of
dynamic iris behavior to the pathogenesis of PACD patients
may vary among those with different AC mechanisms.
The objective of this study was 2-fold: (1) Quantify changes
in IA induced by physiologic and pharmacologic mydriasis in
subgroups with different mechanisms of AC as determined by
AS-OCT and detect any differences between them. (2) Study
the association of such changes with demographic factors,
previously reported ocular biometric measurements as well as
the different mechanisms responsible for AC.
METHODS
Subjects and Ophthalmic Examination
Patients for this observational, cross-sectional study were selected
from the 5-year follow-up of the Handan Eye Study (HES). The HES
was conducted on a sample of rural Chinese adults aged 30 years
or older living in Handan County, Hebei Province.28 From May
2012 to June 2013, surviving members of the original HES cohort
were re-examined for the 5-year follow-up.21
The HES subjects aged ‡40 years who participated in this
follow-up examination between September 2012 and May
2013, underwent gonioscopy and had an occludable angle (the
posterior trabecular meshwork not visible for at least 1808)
were eligible for inclusion. Gonioscopy was performed on all
subjects with a peripheral limbal anterior chamber depth less
than or equal to 40% of peripheral corneal thickness as well as
for 1 in 10 subjects (number 1, 11, 21, and so forth) registered
per day.21 Subjects with previous intraocular surgery, previous
penetrating eye injury, or corneal disorders preventing anterior
chamber assessment and persons taking antiglaucoma eye
drops were excluded, as were those who had suffered an
episode of AAC or had undergone LPI or laser iridoplasty.
Subjects who were on topical or systemic medication that
could affect the iris or angle configuration at the time of the
study (cholinergics or anticholinergics, adrenergic agonists or
antagonists, serotonin, norepinephrine, and dopamine releas-
ers, their precursors or reuptake inhibitors, monoamine
oxidase inhibitors; opioid agonists or antagonists, and hista-
mine receptor antagonists) also were excluded.21
All participants underwent a comprehensive ophthalmic
examination including presenting (PVA) and best corrected
visual acuity (BCVA), using the Early Treatment Diabetic
Retinopathy Study (EDTRS) LogMAR E chart, objective and
subjective refraction, slit-lamp biomicroscopy, visual field
examination, applanation tonometry, gonioscopy, A-scan ultra-
sound biometry, and fundus examination. Refraction was
measured using a KR-8800 auto kerato-refractometer (Topcon,
Tokyo, Japan), visual filed tested using the 24-2 Swedish
Interactive Testing Algorithm (SITA) standard program on a
visual filed analyzer (Humphrey Visual Field Analyzer 740i or
750i; Carl Zeiss, Jena, Germany), and A-scan ultrasound
biometry using an OcuScan RxP (Alcon, Inc., Fort Worth, TX,
USA).21 Static gonioscopy was performed at high magnification
(325) with the eye in the primary gaze position using a
Goldmann-type one-mirror lens under the lowest level of
ambient illumination that permitted a view of the angle.21
Dynamic examination (manipulation) then was performed
using the same lens. Gonioscopy was performed by one of two
observers who were masked to AS-OCT findings.21 The two
observers attained a Kappa (j) of 0.76 for assessment of
occludable angle in 30 eyes (not included in this study).21
The study was approved by the ethics committee of the
Beijing Tongren Hospital and performed in accordance with
the tenets of the Declaration of Helsinki. All subjects provided
verbal and written informed consent.
AS-OCT Imaging
The AS-OCT study uses an infrared light with a wavelength of
1310 nm that optimizes anterior chamber angle imaging in the
absence of visible light spectrum influence on angle configu-
ration and pupil size.29,30 This technique enables cross-
sectional images of the anterior segment of the eye and is
capable of recording transient and dynamic changes of the
FIGURE 1. Angle closure mechanism of pupillary block. FIGURE 2. Angle closure mechanism of plateau iris configuration.
Iris Changes With Mydriasis in Angle Closure IOVS j January 2015 j Vol. 56 j No. 1 j 564
Downloaded From: http://iovs.arvojournals.org/pdfaccess.ashx?url=/data/journals/iovs/933679/ on 02/09/2017
pupil at low levels of illumination.29,30 Each eye was imaged
with an AS-OCT (Visante; Carl Zeiss Meditec, Inc., Dublin, CA,
USA), first under dark conditions (approximately 3 lux, to
induce physiologic mydriasis), then with light (approximately
200 lux), and finally 30 minutes after pharmacologic dilation
with tropicamide 1% eyedrops. Pharmacologic pupil dilation
was not performed on subjects with a broad PAS (‡ 6 clock
hours) because of the high risk of AAC.
Since PACS and PAC/PACG eyes have a risk of AAC post
dilation, the protocol incorporated precautions to recognize and
manage such events. Subjects recording a normal IOP (<21 mm
Hg) at least 1 hour after dilation were allowed to leave.21 Those
with an IOP ‡ 21 mm Hg received IOP-lowering medications as
required.21 The protocol required those with raised IOP at high
risk for an acute event to stay in the central clinic for one night for
further observation and management.21 Doctors in the surround-
ing towns and villages were made aware of the symptoms that
required patients to be sent back to the clinic.21
All images were obtained in the ‘‘anterior segment quadrant’’
mode at 08 to 1808, 458 to 2258, 908 to 2708, and 1358 to 3158
meridians. For image acquisition at 6 and 12 o’clock, the operator
gently retracted the upper and lower lids as needed taking care to
avoid inadvertent pressure on the globe.21 Imaging was repeated
if the scleral spur visibility was poor, and the best set of images
were selected.21 To obtain images in a nonaccommodated state,
the subject’s refractive correction was used to adjust the internal
fixation target for their distance correction.21 The scleral spur was
marked by one of us (ZY) and custom software (Zhongshan Angle
Assessment Program; ZAAP, Guangzhou, China) was used to
measure IA and other parameters.31 This investigator was trained
to identify the scleral spur and has performed measurements
using ZAAP on approximately 10,000 AS-OCT images.
Angle and anterior chamber configuration, including angle
opening distance at 500 lm (AOD500), trabecular-iris space at
500 lm (TISA500), angle recess area (ARA), anterior chamber
depth (ACD), anterior chamber area (ACA), anterior chamber
volume (ACV), anterior chamber width (ACW), and pupil
diameter (PD) also were analyzed with the same software. An
AOD at 500 lm is the distance from the corneal endothelium to
the iris surface as determined from a perpendicular to a line
drawn at 500 lm from the scleral spur.32 The TISA500 is the area
bounded anteriorly by the AOD500 as determined, posteriorly by
a line drawn from the scleral spur perpendicular to the plane of
the inner scleral wall to the iris, superiorly by the inner
corneoscleral wall, and inferiorly by the iris surface.33 The ARA
is the area bordered by the anterior iris surface, corneal
endothelium, and a line perpendicular to the corneal endothe-
lium drawn to the iris surface from a point at 750 lm anterior to
scleral spur.34
Categories of Angle Closure Mechanisms
Four AS-OCT images from each eye obtained in the dark with
clearly discernible scleral spurs were analyzed qualitatively and
categorized into one of three AC mechanisms: PB, plateau iris
configuration (PIC), and thick peripheral iris roll (TPIR). Where
the image suggested more than one mechanism for AC, one of us
(ZY) made a forced choice to select the dominant mechanism
without the benefit of other information. The AC mechanism that
was identified in at least two AS-OCT images of each eye was
determined to be predominant AC mechanism of that eye. In 40
PAC eyes (at the Beijing Tongren Hospital) that underwent UBM
and AS-OCT, the j for such a forced choice of AC mechanism
between the instruments was 0.87 (unpublished data).
FIGURE 3. Angle closure mechanism of thick peripheral iris roll. FIGURE 4. Angle closure mechanism of exaggerated lens vault.
TABLE 1. Demographic Data and Ocular Biometric Measurements of Subjects With Different PAC Mechanisms
Parameter
1 ¼ PB,
n ¼ 110
2 ¼ PIC,
n ¼ 125
3 ¼ TPIR,
n ¼ 129 P Value
P Value,
1 & 2
P Value,
1 & 3
P Value,
2 & 3
Age, y (SD) 63.4 (8.4) 60.9 (7.7) 62.0 (8.7) 0.062*
Male (%) 31 (28.2) 46 (36.8) 42 (32.6) 0.372†
Female (%) 79 (71.8) 79 (63.2) 87 (67.4)
PVA (IR) 0.32 (0.20, 0.40) 0.20 (0.10, 0.40) 0.30 (0.14, 0.44) 0.019‡ 0.012j j 0.425j j 0.026j j
BCVA (IR) 0.10 (0.00, 0.20) 0.00 (0.00, 0.12) 0.07 (0.00, 0.17) 0.137‡
SE (SD) 0.92 (1.48) 0.79 (1.34) 0.82 (1.31) 0.810*
IOP (IR) 12.0 (10.0, 13.5) 12.0 (10.0, 13.5) 12.0 (10.0, 13.0) 0.672‡
CCT (SD) 532 (28) 537 (29) 531 (31) 0.205*
Central ACD (SD) 2.51 (0.24) 2.63 (0.29) 2.53 (0.29) 0.001* 0.002§ 1.000§ 0.013§
LT (IR) 4.90 (4.56, 5.12) 4.75 (4.31, 5.02) 4.89 (4.44, 5.12) 0.039‡ 0.018j j 0.699j j 0.048j j
AL (IR) 22.21 (21.76, 22.92) 22.39 (21.91, 23.18) 22.28 (21.69, 22.28) 0.041‡ 0.034j j 0.983j j 0.026j j
IR, interquartile range.
* A 1-way ANOVA.
† The v2 test.
‡ Kruskal-Wallis test.
§ Bonferroni test.
j j Mann-Whitney test (<0.05/3¼ 0.017¼ significantly different).
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The guidelines to categorize the images into three AC
mechanisms were as follows: (1) PB (Fig. 1): Convex forward
iris profile, giving the typical bombe appearance, a very small
zone of iris-lens contact in the center and shallow peripheral
anterior chamber. (2) PIC (Fig. 2): The peripheral iris rises up
from its root in apposition or in close proximity to the angle
wall and then turns sharply away from the angle toward the
visual axis and central anterior chamber is relatively deep, but
the periphery is shallow. (3) TPIR (Fig. 3): Eyes with this
condition have a thick iris, which is thrown into prominent
peripheral circumferential folds occupying a large proportion
of the angle. The central anterior chamber is relatively deep
but the periphery is shallow.35–38
Statistical Analysis
The IA and PD values represented the average of measurements
from eight iris cross-sections as obtained from AS-OCT scans; the
terms IA and PD are used to designate these average values. Only
the right eye of each subject was included for analysis. The 1-
sample Kolmogorov–Smirnov test was used to assess normality of
the measurements. Variables demonstrating a normal distribution
are presented as mean (SD), while variables failing to achieve a
normal distribution are presented as median (percentiles). The
ANOVA, nonparametric tests, and v2-test were used to compare
differences among the three groups. Linear regression analysis
was used to analyze factors associated with change in IA.
Univariable regression was conducted with changes in IA as the
dependent variable, and the effects of age, sex, central corneal
thickness (CCT), ACD, lens thickness (LT), axial length (AL), PD in
light, PD in dark, PD change, CCD in light, CCD in dark, CCD
change, and AC mechanisms as predictors. Variables that were
significant at a level of P < 0.05 were included in a multivariable
linear regression model. The SPSS statistical software version 17.0
(SPSS, Inc., Chicago, IL, USA) was used for data analysis. Statistical
significance was set at P < 0.05.
RESULTS
Subjects Characteristics
A total of 520 subjects (476 PACS and 44 PAC/PACG) attending the
5-year HES follow-up were eligible for inclusion; 79 eyes (15.2%)
were excluded due to poor image quality and inability to
accurately identify the scleral spur. There were no statistically
significant differences in demographic or ocular features between
included eyes/patients and excluded eyes/patients. We excluded
10 eyes considered to have an exaggerated lens vault (Fig. 4) as
the AC mechanism and 15 eyes in which the dominant AC
mechanism could not be identified. As a small change in pupil size
would not contribute to, or even mask information, 52 eyes with
pupil dilation less than 0.5 mm from light to dark also were
excluded. Following these exclusions, 364 eyes (333 PACS and 31
PAC/PACG) were available for analysis; 110 eyes were determined
to have PB (29.3%), 125 eyes PIC (36.1%), and 129 eyes TPIR
(34.6%) as the dominant mechanism. Considering a PD change as
‡0.5 mm, data from 278 eyes were available for change from light
to dark and for 261 and 264 eyes from change from light or dark to
pharmacological pupil dilation.
The demographic and ocular biometric data of subjects
with each AC mechanism group are shown in Table 1. There
was no significant difference in age, sex, BCVA, spherical
equivalent (SE), IOP, and CCT among the three groups. A
significant difference existed in PVA (P ¼ 0.019), ACD (P ¼
0.001), LT (P¼ 0.039), and AL (P¼ 0.041) among the three AC
mechanisms. Eyes with PIC had better PVA than eyes with PB
(P¼ 0.012), and eyes with PIC had deeper ACD than eyes with
PB and TPIR (P¼ 0.002 and 0.013) as well as a smaller LT (P¼
0.018) compared to the PB group.
TABLE 2. AS-OCT Data of PACD Subjects With Different PAC Mechanisms in the Light
Parameter
1 ¼ PB,
n ¼ 122
2 ¼ PIC,
n ¼ 150
3 ¼ TPIR,
n ¼ 144 P Value*
P Value,
1 & 2†
P Value,
1 & 3†
P Value,
2 & 3†
AOD500, mm (SD) 0.236 (0.099) 0.295 (0.099) 0.226 (0.104) <0.001 <0.001 1.000 <0.001
TISA500, mm2 (SD) 0.102 (0.038) 0.120 (0.042) 0.093 (0.044) <0.001 0.001 0.255 <0.001
ARA, mm2 (SD) 0.273 (0.105) 0.312 (0.115) 0.238 (0.116) <0.001 0.017 0.037 <0.001
ACD, mm (SD) 2.116 (0.266) 2.385 (0.233) 2.234 (0.223) <0.001 <0.001 <0.001 <0.001
ACW, mm (SD) 10.82 (0.44) 11.05 (0.41) 10.86 (0.39) <0.001 <0.001 1.000 <0.001
ACA, mm2 (SD) 14.82 (2.66) 17.26 (2.26) 15.70 (2.29) <0.001 <0.001 0.009 <0.001
ACV, mm3 (SD) 56.85 (13.17) 68.43 (11.43) 60.07 (12.05) <0.001 <0.001 0.098 <0.001
PD, mm (SD) 3.86 (0.72) 3.95 (0.73) 4.05 (0.60) 0.085
* The 1-way ANOVA.
† Bonferroni tests.
TABLE 3. AS-OCT Data of PACD Subjects With Different PAC Mechanisms in the Dark
Parameter
1 ¼ PB,
n ¼ 122
2 ¼ PIC,
n ¼ 150
3 ¼ TPIR,
n ¼ 144 P Value*
P Value,
1 & 2†
P Value,
1 & 3†
P Value,
2 & 3†
AOD500, mm (SD) 0.197 (0.100) 0.262 (0.102) 0.194 (0.112) <0.001 <0.001 1.000 <0.001
TISA500, mm2 (SD) 0.085 (0.039) 0.104 (0.039) 0.078 (0.043) <0.001 <0.001 0.427 <0.001
ARA, mm2 (SD) 0.215 (0.105) 0.260 (0.097) 0.196 (0.110) <0.001 0.001 0.398 <0.001
ACD, mm (SD) 2.131 (0.292) 2.387 (0.225) 2.237 (0.225) <0.001 <0.001 0.001 <0.001
ACW, mm (SD) 10.89 (0.44) 11.08 (0.35) 10.88 (0.40) <0.001 <0.001 1.000 <0.001
ACA, mm2 (SD) 15.22 (2.83) 17.60 (2.27) 16.04 (2.35) <0.001 <0.001 0.023 <0.001
ACV, mm3 (SD) 58.33 (14.04) 70.00 (11.55) 61.25 (12.23) <0.001 <0.001 0.178 <0.001
PD, mm (SD) 4.56 (0.71) 4.65 (0.77) 4.77 (0.65) 0.053
* The 1-way ANOVA.
† Bonferroni test.
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Quantitative anterior chamber parameters measured using
AS-OCT in the three AC mechanisms in light, dark, and after
pharmacologic dilation, along with the differences between
the groups are summarized in Tables 2 to 4. In light and dark
conditions, a significant difference in AOD500, TISA500, ARA,
ACD, ACW, ACA, and ACV was found among the three groups
(P < 0.05). Following pharmacologic dilation, there was a
significant difference in AOD500, TISA500, ACD, ACW, ACA,
and ACV among the three groups (P < 0.05).
Iris Cross-Sectional Area Measurements
A summary of mean IAs from eyes of the three groups
measured in light, dark, and after pharmacologic dilation is
presented in Table 5. There was a significant difference in IA in
light and dark (P  0.001) among the three groups.
Table 6 summarizes changes in IA, IA loss per mm PD
increase, PD, and the ratio of CCD increase relative to PD
increase in the three groups between light to dark, light to
pharmacologic dilation, and dark to pharmacologic dilation.
Differences in the changes of IAs from light to pharmacologic
dilation (P¼ 0.030), IA loss per mm PD increase from light to
pharmacologic dilation (P¼ 0.001), and dark to pharmacologic
dilation (P ¼ 0.011) were observed among the three groups,
and were statistically significant. Bonferroni corrected com-
parisons showed significant differences in the changes of IAs
(P¼0.028) between the PB and TPIR groups. Compared to the
PB and PIC groups, the TPIR group had the greatest IA loss per
mm PD increase from light to pharmacologic dilation (P ¼
0.001 and 0.010) and from dark to pharmacologic dilation (P¼
0.039 and 0.026).
In eyes with PB, partial correlation coefficients were0.800
for IA and PD. Partial correlation coefficients were 0.842 for
IA and PD in eyes with PIC. In eyes with TPIR, Pearson
correlation coefficient for IA and PD was 0.842. Linear
regression analysis showed that IA decreased with increasing
PD over the whole range (light to dark and pharmacologic
dilation) in all three groups (Fig. 5). Change in the IA with
increase in PD (slope¼ 0.315 for PB, 0.324 for PIC, and 0.353
for TPIR) were significantly different between PB and TPIR
groups (P¼ 0.040), but not significantly different between PB
and PIC (P ¼ 0.613), PIC, and TPIR (P ¼ 0.076) groups.
Results of univariable and multivariable linear regression
analysis of IA change from light to dark are shown in Table 7.
Younger age (P < 0.001), larger PD changes (P < 0.001), and
lager CCD distance in the light (P ¼ 0.011) were associated
with greater decrease in IA.
DISCUSSION
The normal iris may freely gain or lose extracellular water from
the spongy stroma and loses volume after physiological or
pharmacological pupil dilation by this mechanism.39 The iris of
PACS and PACD may have more compact or water-retentive
stroma (poor fluid conductivity) that would lose less fluid and
thus retain more volume with pupil dilation.9,10,18,40
Pure pupillary block, pure nonpupillary block, and combi-
nation of multiple mechanisms have been reported to underlie
AC in Chinese eyes with PACD and fit in with the multifactorial
nature of disease.23 Our study is an initial attempt to obtain
insights into the relationship between different AC mecha-
nisms and dynamic iris changes in the pathogenesis of PACS
and PACD. Accordingly, while the eyes in our study had more
than one mechanism underlying AC we identified what we felt
was the dominant mechanism (PB, PIC, and TPIR) present in
each eye. We found differences in iris behavior following
dilation (both physiologic and pharmacologic) in eyes with
these different AC mechanisms.
Compared to pharmacologic dilation, IA loss per mm PD
increase decreased in dark and light in all three groups, with
the smallest decrease in the PB group. While the PD change
was similar, the change in IA per mm change in PD was
significantly different between all three groups for the
comparison between light and pharmacologic dilatation, the
change in condition that produced the largest change in pupil
size. The trend for the PB group loosing the least IA area can be
TABLE 4. AS-OCT Data of PACD Subjects With Different PAC Mechanisms Following Pharmacological Dilation
Parameter
1 ¼ PB,
n ¼ 68
2 ¼ PIC,
n ¼ 100
3 ¼ TPIR,
n ¼ 96 P Value
P Value,
1 & 2
P Value,
1 & 3
P Value,
2 & 3
AOD500, mm (IR) 0.216 (0.176, 0.282) 0.281 (0.209, 0.359) 0.218 (0.158, 0.303) <0.001† <0.001§ 0.939§ <0.001§
TISA500, mm2 (SD) 0.097 (0.034) 0.110 (0.040) 0.095 (0.041) 0.014* 0.085‡ 1.000‡ 0.020‡
ARA, mm2 (SD) 0.283 (0.110) 0.311 (0.122) 0.271 (0.124) 0.062*
ACD, mm (SD) 2.170 (0.263) 2.487 (0.212) 2.336 (0.232) <0.001* <0.001‡ <0.001‡ 0.001‡
ACW, mm (SD) 11.03 (0.39) 11.26 (0.36) 11.08 (0.42) <0.001* 0.001‡ 1.000‡ 0.004‡
ACA, mm2 (SD) 17.69 (2.62) 20.79 (2.23) 19.19 (2.42) <0.001* <0.001‡ <0.001‡ <0.001‡
ACV, mm3 (SD) 75.24 (14.13) 90.68 (12.51) 82.05 (13.51) <0.001* <0.001‡ 0.004‡ <0.001‡
PD, mm (SD) 7.03 (0.49) 7.16 (0.71) 7.19 (0.53) 0.238*
* The 1-way ANOVA.
† Kruskal-Wallis test.
‡ Bonferroni test.
§ Mann-Whitney test (<0.05/3¼ 0.017¼ significantly different).
TABLE 5. IA of Subjects With Different PAC Mechanisms in Three Conditions
Parameter
1 ¼ PB,
n ¼ 68
2 ¼ PIC,
n ¼ 100
3 ¼ TPIR,
n ¼ 96 P Value*
P Value,
1 & 2†
P Value,
1 & 3†
P Value,
2 & 3†
IA in the light, mm2 (SD) 2.81 (0.39) 2.86 (0.39) 3.02 (0.39) <0.001 1.000 <0.001 0.003
IA in the dark, mm2 (SD) 2.67 (0.38) 2.67 (0.37) 2.84 (0.35) 0.001 1.000 0.001 0.001
IA following pharmacological dilation, mm2 (SD) 1.79 (0.30) 1.82 (0.35) 1.87 (0.30) 0.283*
* The 1-way ANOVA.
† Bonferroni test.
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seen with the change in pupil size in different conditions: from
light to dark, dark to pharmacological dilatation, and finally
with light to pharmacological dilation. The IA decreased
relatively linearly with increasing PD in all eyes: the PB group
had the smallest slope and the TPIR group the largest. The
results suggested that dynamic iris change with pupil dilation
may have a more important role in the pathogenesis of PACD in
eyes with PB as the dominant mechanism for AC, compared to
PIC or TPIR.
In PACS and PACD eyes with PB as the dominant AC
mechanism, there is resistance to aqueous flow from the
posterior to anterior chamber at the level of the pupil. This
results from three forces, sphincter and dilator muscles, as well
as iris elasticity, creating a pressure gradient that causes bombe
of the peripheral iris and closure of the angle.41,42 The pressure
gradient between anterior and posterior chamber may affect
the iris structure and change the capacity for free fluid
movement. Almost all eyes with PACD are likely have some
degree of pupillary block.43 The contribution of PB, while
possibly a universally necessary cause, may be less or require a
different set of complementary causative factors where PIC or
TPIR is the dominant mechanism. A lower pressure gradient
between the anterior and posterior chambers with less effect
on capacity for transfer of fluid may explain some of the
differences in dynamic iris change among the three groups.
Previous studies have reported PB as the main mechanism
responsible for AAC.26,27 There is no significant difference in
ACD, LT, and AL between the AAC and contralateral eye44; in
such fellow eyes of Caucasian patients IV increased following
physiologic or pharmacologic pupil dilation.9 However, the
reported IV increase was due to an error in the calculation
formula where greater CCD change with a decreased IA may
result in an increased IV.
Interestingly, subjects with PIC had a better PVA than those
with PB. This was due to the latter having a relatively higher
hypermetropic refractive error and is another indication of the
multiple components and the complexity of AC.
The PACD is clearly a multifactorial disease. The main
weakness in our study is the assumption that there may be a
dominant mechanism involved and the method of determina-
tion of this dominant mechanism. The latter was done using
forced choice by a trained observer and clearly there is a
subjective element involved. It could be argued that the
findings are a mere reflection of the forced choice. In the
absence of more objective methods, we feel the use of a forced
choice by an experienced observer is acceptable as an initial
attempt to determine potential differences (if any) in dynamic
iris changes between the dominant mechanisms hypothesized.
Such a selection does have prior plausibility and is supported
by the sufficient component model of causation used to
identify the role of individual mechanisms in causation in a
multifactorial disease like PACD.6,7,43 The use of the AS-OCT
alone to determine the mechanism is another weakness, but
TABLE 6. Changes in IA and PD After Mydriasis in Subjects With Different PAC Mechanisms
Parameter 1 ¼ PB 2 ¼ PIC 3 ¼ TPIR P Value
P Value,
1 & 2
P Value,
1 & 3
P Value,
2 & 3
L to D, 278 eyes
IA change, mm2 (SD) 0.19 (0.17) 0.22 (0.18) 0.24 (0.24) 0.244*
IA loss per mm PD increase (IR) 0.231 (0.082, 0.351) 0.253 (0.127, 0.392) 0.282 (0.136, 0.385) 0.252†
PD change, mm (SD) 0.95 (0.35) 0.92 (0.32) 0.73 (0.47) 0.768*
Centroid increase/PD increase (SD) 0.434 (0.347) 0.398 (0.379) 0.363 (0.412) 0.452*
L to P, 261 eyes
IA change, mm2 (SD) 1.01 (0.31) 1.07 (0.34) 1.15 (0.33) 0.030* 0.829‡ 0.028‡ 0.278‡
IA loss per mm PD increase (IR) 0.313 (0.279, 0.368) 0.339 (0.300, 0.379) 0.362 (0.311, 0.430) 0.001† 0.082§ 0.001§ 0.010§
PD change, mm (SD) 3.17 (0.68) 3.20 (0.88) 3.14 (0.53) 0.840*
Centroid increase/PD increase (IR) 1.255 (0.878, 1.891) 1.207 (0.769, 1.646) 1.180 (0.859, 1.545) 0.392†
D to P, 264 eyes
IA change, mm2 (SD) 0.87 (0.27) 0.87 (0.30) 0.96 (0.30) 0.059*
IA loss per mm PD increase (SD) 0.361 (0.114) 0.363 (0.105) 0.408 (0.129) 0.011* 1.000‡ 0.039‡ 0.026‡
PD change, mm (SD) 2.46 (0.67) 2.43 (0.83) 2.41 (0.50) 0.908*
Centroid increase/PD increase (IR) 1.004 (0.506, 1.352) 0.882 (0.356, 1.213) 0.880 (0.449, 1.236) 0.380†
L to D, light to dark; L to P, light to after pharmacological dilation; D to P, dark to after pharmacological dilation.
* The 1-way ANOVA.
† Kruskal-Wallis test.
‡ Bonferroni test.
§ Mann-Whitney test (<0.05/3¼ 0.017¼ significant different).
FIGURE 5. Pupillary diameter versus IA. PB y¼0.315xþ 4.061 (R2¼
0.647, P < 0.001, linear regression). PIC y ¼0.324x þ 4.178 (R2 ¼
0.705, P < 0.001, linear regression). TPIR y ¼0.353x þ 4.460 (R2 ¼
0.708, P < 0.001, linear regression). F ¼ 0.506, P ¼ 0.613 (pupillary
block versus plateau iris configuration). F¼ 2.063, P¼ 0.040 (pupillary
block versus thick peripheral iris roll). F¼1.782, P¼0.076 (plateau iris
configuration versus thick peripheral iris roll).
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our earlier unpublished study found a good k with the UBM for
the same observer. In the absence of better methods to
determine the dominant mechanism the data from this initial
study must be considered preliminary while methods to
quantify the identification of the dominant mechanism, if any,
are developed. The way forward should include longitudinal
studies to determine if the dynamic IA loss per mm PD increase
is a significant predictor for progression of PACS (increasing
IOP, formation of PAS, or AAC) that can help identify patients
who need treatment. The IA loss per mm PD increase as a
possible predictive test will be more practical if the safer
approach of comparing bright to dim illumination is used,
since there will be a natural reluctance to pharmacologically
dilate high-risk suspects. Continued planned follow-up of
patients in this study may provide such information, but larger
numbers likely will be needed.
In conclusion, we have presented preliminary insights into
the dynamic iris change in PACS and PACD eyes with different
dominant AC mechanisms in a rural Chinese population. The
data suggested that iris dynamic change may have a more
important role in PACD eyes with PB, compared to those with
PIC or TPIR.
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